세계의 약제-디바이스 병용 시장 규모는 2024년 1,294억 달러에서 예측 기간 중 CAGR 9.1%로 추이하며, 2029년말에는 1,998억 달러에 달할 것으로 예측됩니다.
약제/바이오 제제-디바이스 병용 제품 부문은 2024년 864억 달러에서 CAGR 9.6%로 추이하며, 2029년말에는 1,365억 달러에 달할 것으로 예측됩니다. 또한 약제·바이오 제제 병용 제품 부문은 2024년 304억 달러에서 CAGR 8.6%로 추이하며, 2029년말에는 460억 달러에 달할 것으로 예측됩니다.
세계의 약제-디바이스 병용 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 신규 기술 및 기술개발 동향, 시장 규모 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 개요
시장 전망
조사 범위
시장 개요
제2장 시장 개요
시장 분석
규제 상황
특허 리뷰
제품 리콜
제품 파이프라인
제3장 시장 역학
시장 역학 : 현황
촉진요인
억제요인
과제
기회
무기 전략에 주력하는 주요 기업
제4장 시장 세분화 분석
세분화 내역
약제-디바이스 병용 시장 : 제품 유형별
약제/바이오 제제-디바이스 병용 제품
약제·바이오 제제-디바이스 병용 제품
약제·디바이스-바이오 제제 병용 제품
약제-디바이스 병용 시장 : 용도별
심혈관질환
대사장애
호흡기질환
창상관리
종양
정형외과 질환
기타
지역 목표 내역
약제-디바이스 병용 시장 : 지역별
북미
유럽
아시아태평양
기타 지역
제5장 새로운 동향과 기술
개요
의약품과 의료기기 병용 AI
나노테크놀러지
계산 모델과 시뮬레이션
인간 Organs-on-Chips : 의료 조사에 혁명을 일으킨다.
이식형 약물전달 시스템
무선 임플란트
3D 프린트용 스마트 약물전달 디바이스
신규 약제-디바이스 병용 제품의 최근 승인과 발매
제6장 ESG 도입
약제-디바이스 병용 시장에서 ESG의 지속가능성
ESG 리스크 평가
WHO 가이드라인과 세계 구상
BCC 견해
제7장 경쟁 구도
기업 점유율 분석
M&A·제휴
전략적 제휴
제8장 부록
조사 방법
전시
약어
기업 개요
3M
ABBOTT
B. BRAUN SE
BD
BOSTON SCIENTIFIC CORP.
JOHNSON & JOHNSON SERVICES INC.
MEDTRONIC
SMITH+NEPHEW
STRYKER
TERUMO CORP.
KSA
영문 목차
영문목차
The global market for drug-device combinations is expected to grow from $129.4 billion in 2024 and is projected to reach $199.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2024 to 2029.
The drug/biologic-device combination products market is expected to grow from $86.4 billion in 2024 and is projected to reach $136.5 billion by the end of 2029, at a CAGR of 9.6% during the forecast period of 2024 to 2029.
The drug-biologic combination products market is expected to grow from $30.4 billion in 2024 and is projected to reach $46.0 billion by the end of 2029, at a CAGR of 8.6% during the forecast period of 2024 to 2029.
Report Scope:
The global market for drug-device combination is a rapidly expanding healthcare industry segment, encompassing products that integrate pharmaceutical drugs with medical devices to enhance treatment efficacy and patient convenience. The current report provides a comprehensive introduction and delves into the market for drug-device combinations. It examines market trends of these products, utilizing data from 2021, estimates for 2024 and projections of compound annual growth rates spanning 2024 through 2029 (forecast period) and regional markets of the drug-device combination product market. This report highlights drug-device combinations' current and future market potential and a detailed competitive environment analysis. It covers the regulatory scenario, drivers, restraints, challenges, opportunities, emerging technologies and sustainability in drug-device combinations. The report also covers market projections for 2029 and the market share for key market players. The report informs all market players, potential entrants, government agencies and other interested parties. It covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this study helpful.
Report Includes:
40 data tables and 43 additional tables
Overview of the global markets for drug-device combination (DDC) products and biological devices
Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by product type, application (disease area), and region
Facts and figures pertaining to the market dynamics, current and emerging technologies, regulations, prospects, product recalls, pipeline products, and the expected impact of macroeconomic factors
Review of the industry supply chain, using the Porter's Five Forces model, to analyze the micro- and macro environmental factors prevailing in the marketplace
Overview of ESG developments and sustainability trends in the industry, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices
An analysis of the industry structure, including companies' market shares, alliances, M&A activity and venture funding outlook
Profiles of the leading market players, including Medtronic, Boston Scientific Corp., Stryker, Abbott, and BD
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Market Insights
Regulatory Landscape
Patent Review
Product Recalls
Product Pipeline
Chapter 3 Market Dynamics
Market Dynamics Snapshot
Drivers
Wide Range of Potential Applications of Combinations Products
Growing Prevalence of Chronic Diseases
Empowering Patients: Integrating Homecare Trends with Drug Delivery Advancements
Restraints
Device Reliability and Robustness
Human Factors Testing
Drug and Device Integration
Accommodating Different Volumes
Challenges
Biological Safety Challenges in Drug-Device Combinations
Regulatory Challenges
Opportunities
Technology advancements and Innovative Product Launches
Continuous Growth
Key Players Focusing on Inorganic Strategies in the Drug-Device Combination Products Market
Chapter 4 Market Segmentation Analysis
Segmentation Breakdown
Drug-Device Combinations Market by Product Type
Drug/Biologic-Device Combination Products
Drug-Biologic Drug-Device Combination Products
Drug, Device and Biologic Combination Products
Drug-Device Combinations Market by Application
Cardiovascular Diseases
Metabolic Disorders
Respiratory Diseases
Wound Care
Oncology
Orthopedic Conditions
Others
Geographic Breakdown
Drug-Device Combinations Market, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 5 Emerging Trends and Technologies
Overview
AI in Drug-Device Combination
Nanotechnology
Computational Models and Simulation
Human Organs-on-Chips: Revolutionizing Medical Research
Implantable Drug Delivery Systems
Wireless Implants
Smart Drug Delivery Devices for 3D Printing
Recent Approvals and Launch of Novel Drug-device Combination Products
Chapter 6 ESG Development
Introduction
ESG Sustainability in Drug-Device Combinations Market
